DNAVSSF• 28 Days (Normalized)
DNA vs SF (Ginkgo Bioworks Holdings Inc. vs Stifel Financial Corporation)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $11.47
+68.92%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
SF Performance $69.71
-13.56%
Stifel Financial Corporation
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+82.48 pts
DNA outperforming by 82.48 percentage points
DNASF
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA SF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DNA Price | DNA Gain (%) | SF Price | SF Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $11.47 | +68.92% | $69.71 | -13.56% | +82.48% |
| Oct 06, 2026 | $12.41 | +82.77% | $70.12 | -13.06% | +95.83% |
| Oct 05, 2026 | $14.98 | +120.62% | $70.63 | -12.42% | +133.04% |
| Oct 02, 2026 | $12.35 | +81.89% | $70.28 | -12.86% | +94.75% |
| Oct 01, 2026 | $12.50 | +84.09% | $70.34 | -12.78% | +96.87% |
| Sep 30, 2026 | $12.83 | +88.95% | $70.04 | -13.16% | +102.11% |
| Sep 29, 2026 | $11.96 | +76.14% | $69.70 | -13.58% | +89.72% |
| Sep 28, 2026 | $10.46 | +54.05% | $70.41 | -12.70% | +66.75% |
| Sep 25, 2026 | $10.66 | +57.00% | $70.35 | -12.77% | +69.77% |
| Sep 24, 2026 | $10.25 | +50.96% | $- | - | |
| Sep 23, 2026 | $8.58 | +26.36% | $71.93 | -10.81% | +37.17% |
| Sep 22, 2026 | $9.37 | +38.00% | $73.18 | -9.26% | +47.26% |
| Sep 21, 2026 | $7.98 | +17.53% | $75.72 | -6.11% | +23.64% |
| Sep 18, 2026 | $7.88 | +16.05% | $75.79 | -6.03% | +22.08% |
| Sep 17, 2026 | $7.84 | +15.46% | $75.51 | -6.37% | +21.83% |
Page 1 of 2